Topographic Analysis of EEG Photic Driving in Patients with Schizophrenia following Clozapine Treatment

Fink M. EEG classification of psychoactive compounds in man: A review and theory of behavioral associations. In: Effron DH (ed). Psychopharmacology: A Review of Progress 1957–1967. U.S. Public Health Service Publication No. 1836. Washington, D.C.: U.S. Government Printing Office, 1968: 496–507.

Fink M. EEG and human psychopharmacology. Ann Rev Pharmacol 1969; 9: 241–258.

Itil TM Quantitative pharmaco-electroencephalography in assessing new anti-anxiety agents. In: Vinar O Votava Z Bradley PB (eds). Advances in Neuro-Psycho-Pharmacology. Amsterdam: North Holland, 1971: 199–209.

Itil TM Psychotropical drugs and human EEG. Mod Probl Pharmacopsychiatry. New York: Karger Basel 1974; 8: 43–75.

Schellenberg R Milch W Schwarz A Schober F Dumpfel W. Quantitative EEG and BPRS data following haloperidol-decanoate administration in schizophrenics. Int Clin Psychopharmacology 1994; 9: 17–24.

Schellenberg R Schwarz A Knorr W Haufe C. EEG-brain mapping: A method to optimize therapy in schizophrenics using absolute power and center frequency values. Schizophrenia Research, 1992; 8: 21–29.

Longo VG (ed). Effects of Drugs on the EEG. Amsterdam: Elsevier, 1977.

Koukkou M Angst J Zimmer D. Paroxysmal EEG activity and psychopathology during the treatment with clozapine. Pharmacopsychiatry 1979; 12: 173–183.

Schmauss M Wolff R Erfurth A Ruther E. Tolerability of long term clozapine treatment. Psychopharmacology 1989; 99: 105–108.

Gunther W Baghai T Naber D Spatz R Hippins H. EEG alterations and seizures during treatment with clozapine: A retrospective study of 283 patients. Pharmacopsychiatry 1993; 26: 69–74.

Fink M Irwin P Weinhold P. EEG profile studies of clozapine in volunteer and psychiatric patients. Pharmacopsychiatry 1979; 12: 184–190.

Roubiecek J Prosolt R. Computer analyzed EEG and behavioral changes after psychoactive drugs. Int J Neurology 1975; 10: 33–40.

Roubicek J Major I. EEG profile and behavioral changes after a single dose of clozapine in normals and schizophrenics. Biol Psychiatry 1977; 12: 613–633.

Small J Milstein V Small I Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment-resistant schizophrenia. Clin Electroencephalogr 1987; 18: 124–135.

Saletu B Grunberger J Linzmayer L Anderer P. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. Pharmacopsychiatry 1987; 20: 12–27.

Saletu B Grunberger J. Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects. J Clin Psychiat 1988; 49: 59–71.

Jin Y Potkin SG Rice D Abnormal EEG responses to photic stimulation in schizophrenic patients. Schizoph Bull 1990; 16: 627–633.

Rice DM Potkin SG Jin Y EEG alpha photic driving abnormalities in chronic schizophrenia. Psychiatry Res 1989; 30: 313–324.

Regan D. Human Brain Electrophysiology: Evoked Potentials and Evoked Magnetic Fields in Science and Medicine. New York: Elsevier Science Publishing Co.; 1989.

van der Tweel LH Relation between the psychophysics and electrophysiology of flicker. In: Henkes HE van der Tweel LH (eds). Flicker. The Hague: Junk; 1964; 287–304.

Spekreijse H. Analysis of EEG Responses in Man. The Hague: Junk; 1966. Thesis.

Andersen P Andersson SA Physiological Basis of the Alpha Rhythm. New York: Meredith Corp; 1968.

da Silva Lopes F Neural mechanisms underlying brain waves: From neural membranes to networks. Electroencephalogr Clin Neurophysiol 1991; 79: 81–93.

Potkin SG Jin Y Rinaldi PC Thalamic model of schizophrenia: Neuropsychological, EEG and PET studies. Presented at the Society of Biological Psychiatry Annual Meeting, Biol Psychiatry 1993; 33(6A).

Jin Y Sandman C Wu J Topographic analysis of EEG photic driving in normal and schizophrenic subjects. Clin Electroencephalogr 1995; 26: 102–107.

Jin Y Potkin SG Sandman CA Bunney WE Jr. EEG photic driving in patients with schizophrenia and depression. Biol Psychiatry 1997 41: 496–499.

Jin Y Potkin SG Sandman C Clozapine increases EEG photic driving in clinical responders. Schizoph Bull 1995; 21: 263–268.

Duffy FH Burchfiel JL Lombroso CT Brain electrical activity mapping (BEAM): A method for extending the clinical utility of EEG and evoked potential data. Ann Neurol 1979; 5: 309–321.

Duffy FH Denckla MB Bartels PH Sandini G Kiessling LS Dyslexia: Automated diagnosis by computerized classification of brain electrical activity. Ann Neurol 1980; 7: 421–428.

Duffy FH Bartels PH Burchfiel JL Significance probability mapping: An aid in the topographic analysis of brain electrical activity. Electroencephalogr Clin Neurophysiol 1981; 51: 455–462.

Meltzer HY Clinical studies on the mechanism of action of clozapine: The domapine-serotonin hypothesis of schizophrenia. Psychopharmacology 1989; 99: S18–S27.

Millson DS Haworth SJ Rushton A Wilkinson D Hobson S Harry J. The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers. Br J Clin Pharm 1991; 32: 447–454.

Coenen AM Ates N Skarsfeldt T van Luijtelaar EL Effects of sertindole on sleep-wake states, electroencephalogram, behavioral patterns, and epileptic activity of rats. Pharmacol Biochem Behav 1995; 51: 353–357.

Seifritz E Moore P Trachsel L Bhatti T Stahl SM Gillin JC The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci Letters 1996; 209: 41–44.

Wetzel H Szegedi A Hain C Wiesner J Schlegel S Benkert O. Seroquel (ICI 204 636), a putative “atypical” antipsychotic, in schizophrenia with positive symptomatology: Results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Psychopharmacology 1995; 119: 231–238.